#METABOLOMICS WORKBENCH WangLab_20230227_072523 DATATRACK_ID:3766 STUDY_ID:ST002500 ANALYSIS_ID:AN004109 PROJECT_ID:PR001614
VERSION             	1
CREATED_ON             	March 1, 2023, 5:39 pm
#PROJECT
PR:PROJECT_TITLE                 	Study on human plasma metabolomics
PR:PROJECT_TYPE                  	MS quantitative analysis
PR:PROJECT_SUMMARY               	Multicenter quantitative metabolomics study of samples from human sources
PR:INSTITUTE                     	Soochow University
PR:LAST_NAME                     	Wang
PR:FIRST_NAME                    	Chang
PR:ADDRESS                       	No. 199, Renai Road, Suzhou Industrial Park
PR:EMAIL                         	wangchang@suda.edu.cn
PR:PHONE                         	+86-512-65880067
#STUDY
ST:STUDY_TITLE                   	Plasma metabolomic signatures from patients following high-dose total body
ST:STUDY_TITLE                   	irradiation
ST:STUDY_SUMMARY                 	Plasma metabolic characteristics were investigated from patients of
ST:STUDY_SUMMARY                 	hematopoietic stem cell transplantation following high-dose TBI pretreatment
ST:STUDY_SUMMARY                 	utilizing gas chromatography-mass spectrometry (GC-MS) and liquid
ST:STUDY_SUMMARY                 	chromatography-mass spectrometry (LC-MS).
ST:INSTITUTE                     	Soochow University
ST:LAST_NAME                     	Wang
ST:FIRST_NAME                    	Chang
ST:ADDRESS                       	No. 199, Renai Road, Suzhou Industrial Park
ST:EMAIL                         	wangchang@suda.edu.cn
ST:PHONE                         	+8651265880067
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
SU:GENDER                        	
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	TBI-50	neg-Pre-TBI-1	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A01.raw
SUBJECT_SAMPLE_FACTORS           	TBI-58	neg-Pre-TBI-2	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A02.raw
SUBJECT_SAMPLE_FACTORS           	TBI-41	neg-Pre-TBI-5	Treatment:Control	Sex=Female; Batch=1a; RAW_FILE_NAME=20180721A03.raw
SUBJECT_SAMPLE_FACTORS           	TBI-55	neg-Pre-TBI-6	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A04.raw
SUBJECT_SAMPLE_FACTORS           	TBI-67	neg-Pre-TBI-7	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A05.raw
SUBJECT_SAMPLE_FACTORS           	TBI-49	neg-Pre-TBI-8	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A06.raw
SUBJECT_SAMPLE_FACTORS           	TBI-52	neg-Pre-TBI-9	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A07.raw
SUBJECT_SAMPLE_FACTORS           	TBI-48	neg-Pre-TBI-10	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A08.raw
SUBJECT_SAMPLE_FACTORS           	TBI-70	neg-Pre-TBI-11	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A09.raw
SUBJECT_SAMPLE_FACTORS           	TBI-64	neg-Pre-TBI-12	Treatment:Control	Sex=Female; Batch=1a; RAW_FILE_NAME=20180721A10.raw
SUBJECT_SAMPLE_FACTORS           	TBI-71	neg-Pre-TBI-13	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A11.raw
SUBJECT_SAMPLE_FACTORS           	TBI-53	neg-Pre-TBI-14	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A12.raw
SUBJECT_SAMPLE_FACTORS           	TBI-76	neg-Pre-TBI-15	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A13.raw
SUBJECT_SAMPLE_FACTORS           	TBI-47	neg-Pre-TBI-16	Treatment:Control	Sex=Female; Batch=1a; RAW_FILE_NAME=20180721A14.raw
SUBJECT_SAMPLE_FACTORS           	TBI-59	neg-Pre-TBI-17	Treatment:Control	Sex=Female; Batch=1a; RAW_FILE_NAME=20180721A15.raw
SUBJECT_SAMPLE_FACTORS           	TBI-72	neg-Pre-TBI-18	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A16.raw
SUBJECT_SAMPLE_FACTORS           	TBI-57	neg-Pre-TBI-19	Treatment:Control	Sex=Female; Batch=1a; RAW_FILE_NAME=20180721A18.raw
SUBJECT_SAMPLE_FACTORS           	TBI-45	neg-Pre-TBI-20	Treatment:Control	Sex=Female; Batch=1a; RAW_FILE_NAME=20180721A19.raw
SUBJECT_SAMPLE_FACTORS           	TBI-43	neg-Pre-TBI-21	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A20.raw
SUBJECT_SAMPLE_FACTORS           	TBI-68	neg-Pre-TBI-22	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A21.raw
SUBJECT_SAMPLE_FACTORS           	TBI-73	neg-Pre-TBI-23	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A22.raw
SUBJECT_SAMPLE_FACTORS           	TBI-78	neg-Pre-TBI-24	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A23.raw
SUBJECT_SAMPLE_FACTORS           	TBI-77	neg-Pre-TBI-25	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A24.raw
SUBJECT_SAMPLE_FACTORS           	TBI-61	neg-Pre-TBI-26	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A25.raw
SUBJECT_SAMPLE_FACTORS           	TBI-66	neg-Pre-TBI-27	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A27.raw
SUBJECT_SAMPLE_FACTORS           	TBI-75	neg-Pre-TBI-28	Treatment:Control	Sex=Female; Batch=1a; RAW_FILE_NAME=20180721A28.raw
SUBJECT_SAMPLE_FACTORS           	TBI-62	neg-Pre-TBI-29	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A29.raw
SUBJECT_SAMPLE_FACTORS           	TBI-74	neg-Pre-TBI-30	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A30.raw
SUBJECT_SAMPLE_FACTORS           	TBI-56	neg-Pre-TBI-31	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A31.raw
SUBJECT_SAMPLE_FACTORS           	TBI-60	neg-Pre-TBI-32	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A32.raw
SUBJECT_SAMPLE_FACTORS           	TBI-69	neg-Pre-TBI-33	Treatment:Control	Sex=Female; Batch=1a; RAW_FILE_NAME=20180721A33.raw
SUBJECT_SAMPLE_FACTORS           	TBI-46	neg-Pre-TBI-34	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A35.raw
SUBJECT_SAMPLE_FACTORS           	TBI-79	neg-Pre-TBI-35	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A36.raw
SUBJECT_SAMPLE_FACTORS           	TBI-65	neg-Pre-TBI-36	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A37.raw
SUBJECT_SAMPLE_FACTORS           	TBI-63	neg-Pre-TBI-37	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A38.raw
SUBJECT_SAMPLE_FACTORS           	TBI-42	neg-Pre-TBI-38	Treatment:Control	Sex=Male; Batch=1a; RAW_FILE_NAME=20180721A39.raw
SUBJECT_SAMPLE_FACTORS           	TBI-1	neg-TBI-1	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072101.raw
SUBJECT_SAMPLE_FACTORS           	TBI-2	neg-TBI-2	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072102.raw
SUBJECT_SAMPLE_FACTORS           	TBI-3	neg-TBI-5	Treatment:TBI	Sex=Female; Batch=1a; RAW_FILE_NAME=2018072103.raw
SUBJECT_SAMPLE_FACTORS           	TBI-4	neg-TBI-6	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072104.raw
SUBJECT_SAMPLE_FACTORS           	TBI-5	neg-TBI-7	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072105.raw
SUBJECT_SAMPLE_FACTORS           	TBI-6	neg-TBI-8	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072106.raw
SUBJECT_SAMPLE_FACTORS           	TBI-7	neg-TBI-9	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072107.raw
SUBJECT_SAMPLE_FACTORS           	TBI-8	neg-TBI-10	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072108.raw
SUBJECT_SAMPLE_FACTORS           	TBI-9	neg-TBI-11	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072109.raw
SUBJECT_SAMPLE_FACTORS           	TBI-10	neg-TBI-12	Treatment:TBI	Sex=Female; Batch=1a; RAW_FILE_NAME=2018072110.raw
SUBJECT_SAMPLE_FACTORS           	TBI-11	neg-TBI-13	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072111.raw
SUBJECT_SAMPLE_FACTORS           	TBI-12	neg-TBI-14	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072112.raw
SUBJECT_SAMPLE_FACTORS           	TBI-13	neg-TBI-15	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072113.raw
SUBJECT_SAMPLE_FACTORS           	TBI-14	neg-TBI-16	Treatment:TBI	Sex=Female; Batch=1a; RAW_FILE_NAME=2018072114.raw
SUBJECT_SAMPLE_FACTORS           	TBI-15	neg-TBI-17	Treatment:TBI	Sex=Female; Batch=1a; RAW_FILE_NAME=2018072115.raw
SUBJECT_SAMPLE_FACTORS           	TBI-16	neg-TBI-18	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072116.raw
SUBJECT_SAMPLE_FACTORS           	TBI-18	neg-TBI-19	Treatment:TBI	Sex=Female; Batch=1a; RAW_FILE_NAME=2018072118.raw
SUBJECT_SAMPLE_FACTORS           	TBI-19	neg-TBI-20	Treatment:TBI	Sex=Female; Batch=1a; RAW_FILE_NAME=2018072119.raw
SUBJECT_SAMPLE_FACTORS           	TBI-20	neg-TBI-21	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072120.raw
SUBJECT_SAMPLE_FACTORS           	TBI-21	neg-TBI-22	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072121.raw
SUBJECT_SAMPLE_FACTORS           	TBI-22	neg-TBI-23	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072122.raw
SUBJECT_SAMPLE_FACTORS           	TBI-23	neg-TBI-24	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072123.raw
SUBJECT_SAMPLE_FACTORS           	TBI-24	neg-TBI-25	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072124.raw
SUBJECT_SAMPLE_FACTORS           	TBI-25	neg-TBI-26	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072125.raw
SUBJECT_SAMPLE_FACTORS           	TBI-27	neg-TBI-27	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072127.raw
SUBJECT_SAMPLE_FACTORS           	TBI-28	neg-TBI-28	Treatment:TBI	Sex=Female; Batch=1a; RAW_FILE_NAME=2018072128.raw
SUBJECT_SAMPLE_FACTORS           	TBI-29	neg-TBI-29	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072129.raw
SUBJECT_SAMPLE_FACTORS           	TBI-30	neg-TBI-30	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072130.raw
SUBJECT_SAMPLE_FACTORS           	TBI-31	neg-TBI-31	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072131.raw
SUBJECT_SAMPLE_FACTORS           	TBI-32	neg-TBI-32	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072132.raw
SUBJECT_SAMPLE_FACTORS           	TBI-33	neg-TBI-33	Treatment:TBI	Sex=Female; Batch=1a; RAW_FILE_NAME=2018072133.raw
SUBJECT_SAMPLE_FACTORS           	TBI-35	neg-TBI-34	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072135.raw
SUBJECT_SAMPLE_FACTORS           	TBI-36	neg-TBI-35	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072136.raw
SUBJECT_SAMPLE_FACTORS           	TBI-37	neg-TBI-36	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072137.raw
SUBJECT_SAMPLE_FACTORS           	TBI-38	neg-TBI-37	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072138.raw
SUBJECT_SAMPLE_FACTORS           	TBI-39	neg-TBI-38	Treatment:TBI	Sex=Male; Batch=1a; RAW_FILE_NAME=2018072139.raw
SUBJECT_SAMPLE_FACTORS           	TBI-50	pos-Pre-TBI-1	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A01.raw
SUBJECT_SAMPLE_FACTORS           	TBI-58	pos-Pre-TBI-2	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A02.raw
SUBJECT_SAMPLE_FACTORS           	TBI-41	pos-Pre-TBI-5	Treatment:Control	Sex=Female; Batch=1b; RAW_FILE_NAME=20180720A03.raw
SUBJECT_SAMPLE_FACTORS           	TBI-55	pos-Pre-TBI-6	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A04.raw
SUBJECT_SAMPLE_FACTORS           	TBI-67	pos-Pre-TBI-7	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A05.raw
SUBJECT_SAMPLE_FACTORS           	TBI-49	pos-Pre-TBI-8	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A06.raw
SUBJECT_SAMPLE_FACTORS           	TBI-52	pos-Pre-TBI-9	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A07.raw
SUBJECT_SAMPLE_FACTORS           	TBI-48	pos-Pre-TBI-10	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A08.raw
SUBJECT_SAMPLE_FACTORS           	TBI-70	pos-Pre-TBI-11	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A09.raw
SUBJECT_SAMPLE_FACTORS           	TBI-64	pos-Pre-TBI-12	Treatment:Control	Sex=Female; Batch=1b; RAW_FILE_NAME=20180720A10.raw
SUBJECT_SAMPLE_FACTORS           	TBI-71	pos-Pre-TBI-13	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A11.raw
SUBJECT_SAMPLE_FACTORS           	TBI-53	pos-Pre-TBI-14	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A12.raw
SUBJECT_SAMPLE_FACTORS           	TBI-76	pos-Pre-TBI-15	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A13.raw
SUBJECT_SAMPLE_FACTORS           	TBI-47	pos-Pre-TBI-16	Treatment:Control	Sex=Female; Batch=1b; RAW_FILE_NAME=20180720A14.raw
SUBJECT_SAMPLE_FACTORS           	TBI-59	pos-Pre-TBI-17	Treatment:Control	Sex=Female; Batch=1b; RAW_FILE_NAME=20180720A15.raw
SUBJECT_SAMPLE_FACTORS           	TBI-72	pos-Pre-TBI-18	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A16.raw
SUBJECT_SAMPLE_FACTORS           	TBI-57	pos-Pre-TBI-19	Treatment:Control	Sex=Female; Batch=1b; RAW_FILE_NAME=20180720A18.raw
SUBJECT_SAMPLE_FACTORS           	TBI-45	pos-Pre-TBI-20	Treatment:Control	Sex=Female; Batch=1b; RAW_FILE_NAME=20180720A19.raw
SUBJECT_SAMPLE_FACTORS           	TBI-43	pos-Pre-TBI-21	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A20.raw
SUBJECT_SAMPLE_FACTORS           	TBI-68	pos-Pre-TBI-22	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A21.raw
SUBJECT_SAMPLE_FACTORS           	TBI-73	pos-Pre-TBI-23	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A22.raw
SUBJECT_SAMPLE_FACTORS           	TBI-78	pos-Pre-TBI-24	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A23.raw
SUBJECT_SAMPLE_FACTORS           	TBI-77	pos-Pre-TBI-25	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A24.raw
SUBJECT_SAMPLE_FACTORS           	TBI-61	pos-Pre-TBI-26	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A25.raw
SUBJECT_SAMPLE_FACTORS           	TBI-66	pos-Pre-TBI-27	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A27.raw
SUBJECT_SAMPLE_FACTORS           	TBI-75	pos-Pre-TBI-28	Treatment:Control	Sex=Female; Batch=1b; RAW_FILE_NAME=20180720A28.raw
SUBJECT_SAMPLE_FACTORS           	TBI-62	pos-Pre-TBI-29	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A29.raw
SUBJECT_SAMPLE_FACTORS           	TBI-74	pos-Pre-TBI-30	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A30.raw
SUBJECT_SAMPLE_FACTORS           	TBI-56	pos-Pre-TBI-31	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A31.raw
SUBJECT_SAMPLE_FACTORS           	TBI-60	pos-Pre-TBI-32	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A32.raw
SUBJECT_SAMPLE_FACTORS           	TBI-69	pos-Pre-TBI-33	Treatment:Control	Sex=Female; Batch=1b; RAW_FILE_NAME=20180720A33.raw
SUBJECT_SAMPLE_FACTORS           	TBI-46	pos-Pre-TBI-34	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A35.raw
SUBJECT_SAMPLE_FACTORS           	TBI-79	pos-Pre-TBI-35	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A36.raw
SUBJECT_SAMPLE_FACTORS           	TBI-65	pos-Pre-TBI-36	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A37.raw
SUBJECT_SAMPLE_FACTORS           	TBI-63	pos-Pre-TBI-37	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A38.raw
SUBJECT_SAMPLE_FACTORS           	TBI-42	pos-Pre-TBI-38	Treatment:Control	Sex=Male; Batch=1b; RAW_FILE_NAME=20180720A39.raw
SUBJECT_SAMPLE_FACTORS           	TBI-1	pos-TBI-1	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071901.raw
SUBJECT_SAMPLE_FACTORS           	TBI-2	pos-TBI-2	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071902.raw
SUBJECT_SAMPLE_FACTORS           	TBI-3	pos-TBI-5	Treatment:TBI	Sex=Female; Batch=1b; RAW_FILE_NAME=2018071903.raw
SUBJECT_SAMPLE_FACTORS           	TBI-4	pos-TBI-6	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071904.raw
SUBJECT_SAMPLE_FACTORS           	TBI-5	pos-TBI-7	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071905.raw
SUBJECT_SAMPLE_FACTORS           	TBI-6	pos-TBI-8	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071906.raw
SUBJECT_SAMPLE_FACTORS           	TBI-7	pos-TBI-9	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071907.raw
SUBJECT_SAMPLE_FACTORS           	TBI-8	pos-TBI-10	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071908.raw
SUBJECT_SAMPLE_FACTORS           	TBI-9	pos-TBI-11	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071909.raw
SUBJECT_SAMPLE_FACTORS           	TBI-10	pos-TBI-12	Treatment:TBI	Sex=Female; Batch=1b; RAW_FILE_NAME=2018071910.raw
SUBJECT_SAMPLE_FACTORS           	TBI-11	pos-TBI-13	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071911.raw
SUBJECT_SAMPLE_FACTORS           	TBI-12	pos-TBI-14	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071912.raw
SUBJECT_SAMPLE_FACTORS           	TBI-13	pos-TBI-15	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071913.raw
SUBJECT_SAMPLE_FACTORS           	TBI-14	pos-TBI-16	Treatment:TBI	Sex=Female; Batch=1b; RAW_FILE_NAME=2018071914.raw
SUBJECT_SAMPLE_FACTORS           	TBI-15	pos-TBI-17	Treatment:TBI	Sex=Female; Batch=1b; RAW_FILE_NAME=2018071915.raw
SUBJECT_SAMPLE_FACTORS           	TBI-16	pos-TBI-18	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071916.raw
SUBJECT_SAMPLE_FACTORS           	TBI-18	pos-TBI-19	Treatment:TBI	Sex=Female; Batch=1b; RAW_FILE_NAME=2018071918.raw
SUBJECT_SAMPLE_FACTORS           	TBI-19	pos-TBI-20	Treatment:TBI	Sex=Female; Batch=1b; RAW_FILE_NAME=2018071919.raw
SUBJECT_SAMPLE_FACTORS           	TBI-20	pos-TBI-21	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071920.raw
SUBJECT_SAMPLE_FACTORS           	TBI-21	pos-TBI-22	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071921.raw
SUBJECT_SAMPLE_FACTORS           	TBI-22	pos-TBI-23	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071922.raw
SUBJECT_SAMPLE_FACTORS           	TBI-23	pos-TBI-24	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071923.raw
SUBJECT_SAMPLE_FACTORS           	TBI-24	pos-TBI-25	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071924.raw
SUBJECT_SAMPLE_FACTORS           	TBI-25	pos-TBI-26	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071925.raw
SUBJECT_SAMPLE_FACTORS           	TBI-27	pos-TBI-27	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071927.raw
SUBJECT_SAMPLE_FACTORS           	TBI-28	pos-TBI-28	Treatment:TBI	Sex=Female; Batch=1b; RAW_FILE_NAME=2018071928.raw
SUBJECT_SAMPLE_FACTORS           	TBI-29	pos-TBI-29	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071929.raw
SUBJECT_SAMPLE_FACTORS           	TBI-30	pos-TBI-30	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071930.raw
SUBJECT_SAMPLE_FACTORS           	TBI-31	pos-TBI-31	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071931.raw
SUBJECT_SAMPLE_FACTORS           	TBI-32	pos-TBI-32	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071932.raw
SUBJECT_SAMPLE_FACTORS           	TBI-33	pos-TBI-33	Treatment:TBI	Sex=Female; Batch=1b; RAW_FILE_NAME=2018071933.raw
SUBJECT_SAMPLE_FACTORS           	TBI-35	pos-TBI-34	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071935.raw
SUBJECT_SAMPLE_FACTORS           	TBI-36	pos-TBI-35	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071936.raw
SUBJECT_SAMPLE_FACTORS           	TBI-37	pos-TBI-36	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071937.raw
SUBJECT_SAMPLE_FACTORS           	TBI-38	pos-TBI-37	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071938.raw
SUBJECT_SAMPLE_FACTORS           	TBI-39	pos-TBI-38	Treatment:TBI	Sex=Male; Batch=1b; RAW_FILE_NAME=2018071939.raw
SUBJECT_SAMPLE_FACTORS           	TBI-50	GC-Pre-TBI-1	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A1.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-58	GC-Pre-TBI-2	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A2.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-41	GC-Pre-TBI-5	Treatment:Control	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-A3.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-55	GC-Pre-TBI-6	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A4.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-67	GC-Pre-TBI-7	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A5.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-49	GC-Pre-TBI-8	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A6.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-52	GC-Pre-TBI-9	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A7.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-48	GC-Pre-TBI-10	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A8.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-70	GC-Pre-TBI-11	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A9.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-64	GC-Pre-TBI-12	Treatment:Control	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-A10.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-71	GC-Pre-TBI-13	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A11.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-53	GC-Pre-TBI-14	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A12.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-76	GC-Pre-TBI-15	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A13.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-47	GC-Pre-TBI-16	Treatment:Control	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-A14.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-59	GC-Pre-TBI-17	Treatment:Control	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-A15.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-72	GC-Pre-TBI-18	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A16.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-57	GC-Pre-TBI-19	Treatment:Control	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-A18.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-45	GC-Pre-TBI-20	Treatment:Control	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-A19.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-43	GC-Pre-TBI-21	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A20.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-68	GC-Pre-TBI-22	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A21.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-73	GC-Pre-TBI-23	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A22.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-78	GC-Pre-TBI-24	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A23.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-77	GC-Pre-TBI-25	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A24.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-61	GC-Pre-TBI-26	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A25.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-66	GC-Pre-TBI-27	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A27.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-75	GC-Pre-TBI-28	Treatment:Control	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-A28.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-62	GC-Pre-TBI-29	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A29.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-74	GC-Pre-TBI-30	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A30.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-56	GC-Pre-TBI-31	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A31.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-60	GC-Pre-TBI-32	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A32.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-69	GC-Pre-TBI-33	Treatment:Control	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-A33.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-46	GC-Pre-TBI-34	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A35.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-79	GC-Pre-TBI-35	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A36.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-65	GC-Pre-TBI-36	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A37.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-63	GC-Pre-TBI-37	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A38.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-42	GC-Pre-TBI-38	Treatment:Control	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-A39.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-1	GC-TBI-1	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-1.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-2	GC-TBI-2	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-2.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-3	GC-TBI-5	Treatment:TBI	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-3.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-4	GC-TBI-6	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-4.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-5	GC-TBI-7	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-5.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-6	GC-TBI-8	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-6.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-7	GC-TBI-9	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-7.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-8	GC-TBI-10	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-8.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-9	GC-TBI-11	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-9.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-10	GC-TBI-12	Treatment:TBI	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-10.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-11	GC-TBI-13	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-11.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-12	GC-TBI-14	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-12.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-13	GC-TBI-15	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-13.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-14	GC-TBI-16	Treatment:TBI	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-14.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-15	GC-TBI-17	Treatment:TBI	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-15.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-16	GC-TBI-18	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-16.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-18	GC-TBI-19	Treatment:TBI	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-18.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-19	GC-TBI-20	Treatment:TBI	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-19.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-20	GC-TBI-21	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-20.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-21	GC-TBI-22	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-21.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-22	GC-TBI-23	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-22.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-23	GC-TBI-24	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-23.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-24	GC-TBI-25	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-24.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-25	GC-TBI-26	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-25.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-27	GC-TBI-27	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-27.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-28	GC-TBI-28	Treatment:TBI	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-28.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-29	GC-TBI-29	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-29.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-30	GC-TBI-30	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-30.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-31	GC-TBI-31	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-31.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-32	GC-TBI-32	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-32.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-33	GC-TBI-33	Treatment:TBI	Sex=Female; Batch=2; RAW_FILE_NAME=TBI-33.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-35	GC-TBI-34	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-35.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-36	GC-TBI-35	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-36.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-37	GC-TBI-36	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-37.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-38	GC-TBI-37	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-38.CDF
SUBJECT_SAMPLE_FACTORS           	TBI-39	GC-TBI-38	Treatment:TBI	Sex=Male; Batch=2; RAW_FILE_NAME=TBI-39.CDF
#COLLECTION
CO:COLLECTION_SUMMARY            	whole blood was collected prior to irradiation (3 days before the first dose of
CO:COLLECTION_SUMMARY            	TBI) and at approximately 72h after the end of radiation.
CO:SAMPLE_TYPE                   	Blood (whole)
#TREATMENT
TR:TREATMENT_SUMMARY             	36 patients (28 male and 8 female) received 2 Gy twice a day for three
TR:TREATMENT_SUMMARY             	consecutive days (total dose of 12 Gy) at a dose rate 8cGy/min using a six MV
TR:TREATMENT_SUMMARY             	medical linear accelerator (Siemens, KD22). The lung was shielded and the dose
TR:TREATMENT_SUMMARY             	of supplemental electron fields was no more than 8 Gy.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	GC-MS: 200μL of methanol containing 0.5μg/ml tridecanoic acid (IS) was added
SP:SAMPLEPREP_SUMMARY            	into 50μL plasma. After vortexmixing, the solution was centrifuged at 13000 rpm
SP:SAMPLEPREP_SUMMARY            	for 15 min at 4 ℃. Then the supernatant was transferred into a new eppendorf
SP:SAMPLEPREP_SUMMARY            	tube and dried by vacuum (LABCONCO, USA). The dried sample was re-dissolved in
SP:SAMPLEPREP_SUMMARY            	50μL methoxyamine solution (20 mg/mL) for the oximation reaction (37℃,1.5h),
SP:SAMPLEPREP_SUMMARY            	which was followed by a silylation reaction with 50μL MSTFA (37℃,1.5h).
SP:SAMPLEPREP_SUMMARY            	Finally, the derivatized sample was centrifuged at 13 000 rpm for 15 min and the
SP:SAMPLEPREP_SUMMARY            	supernatant was used for the GC-MS analysis. LC-MS: The internal standards
SP:SAMPLEPREP_SUMMARY            	(ISs) were dissolved in acetonitrile including d4-choline (d4-CA, 8μg/mL),
SP:SAMPLEPREP_SUMMARY            	C19:0 lysoPC (4μg/mL), C17:0-C17:0 PC (8μg/mL), C17:0-C17:0 PE (8μg/mL),
SP:SAMPLEPREP_SUMMARY            	d3-C16:0 free fatty acids (d3-C16:0 FFA, 8μg/mL), d4-cholic acid (CA, 4μg/mL)
SP:SAMPLEPREP_SUMMARY            	and d4-chenodeoxycholic acid (d4-CDCA, 4μg/mL). For LC-MS analysis, 200 μL ISs
SP:SAMPLEPREP_SUMMARY            	was added into 50 μL plasma sample for the protein precipitation. After
SP:SAMPLEPREP_SUMMARY            	vortexing, the sample was centrifuged for 10 min (14,000 rpm, 4 ℃), the
SP:SAMPLEPREP_SUMMARY            	supernatant (180 μL ) was redissolved with 100μ L 50% methanol before LC-MS
SP:SAMPLEPREP_SUMMARY            	analysis.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	negative ion mode
CH:CHROMATOGRAPHY_TYPE           	HILIC
CH:INSTRUMENT_NAME               	Thermo TSQ Vantage HPLC-MS/MS
CH:COLUMN_NAME                   	Waters ACQUITY UPLC HSS T3 (100 x 2.1mm,1.8um)
CH:SOLVENT_A                     	water(5 mM ammonium bicarbonate )
CH:SOLVENT_B                     	95% methanol/water(5mM ammonium bicarbonate )
CH:FLOW_GRADIENT                 	0-1min,0.1%B;1-3min,0.1-40%B;3-5min,40-100%B;5-10.5min,100%B;10.5-10.6min,0.1%B;10.6-18min
CH:FLOW_RATE                     	0.25 mL/min
CH:COLUMN_TEMPERATURE            	50
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo TSQ Vantage
MS:INSTRUMENT_TYPE               	Triple quadrupole
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	350℃capillary temperature, 300℃ vaporize temperature, 40 arbitrary units
MS:MS_COMMENTS                   	sheath gas flow rate, 20 arbitrary units auxiliary gas flow rate, -2.5 kV
MS:MS_COMMENTS                   	capillary voltage
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	pmoles/l
MS_METABOLITE_DATA_START
Samples	neg-Pre-TBI-1	neg-Pre-TBI-2	neg-Pre-TBI-5	neg-Pre-TBI-6	neg-Pre-TBI-7	neg-Pre-TBI-8	neg-Pre-TBI-9	neg-Pre-TBI-10	neg-Pre-TBI-11	neg-Pre-TBI-12	neg-Pre-TBI-13	neg-Pre-TBI-14	neg-Pre-TBI-15	neg-Pre-TBI-16	neg-Pre-TBI-17	neg-Pre-TBI-18	neg-Pre-TBI-19	neg-Pre-TBI-20	neg-Pre-TBI-21	neg-Pre-TBI-22	neg-Pre-TBI-23	neg-Pre-TBI-24	neg-Pre-TBI-25	neg-Pre-TBI-26	neg-Pre-TBI-27	neg-Pre-TBI-28	neg-Pre-TBI-29	neg-Pre-TBI-30	neg-Pre-TBI-31	neg-Pre-TBI-32	neg-Pre-TBI-33	neg-Pre-TBI-34	neg-Pre-TBI-35	neg-Pre-TBI-36	neg-Pre-TBI-37	neg-Pre-TBI-38	neg-TBI-1	neg-TBI-2	neg-TBI-5	neg-TBI-6	neg-TBI-7	neg-TBI-8	neg-TBI-9	neg-TBI-10	neg-TBI-11	neg-TBI-12	neg-TBI-13	neg-TBI-14	neg-TBI-15	neg-TBI-16	neg-TBI-17	neg-TBI-18	neg-TBI-19	neg-TBI-20	neg-TBI-21	neg-TBI-22	neg-TBI-23	neg-TBI-24	neg-TBI-25	neg-TBI-26	neg-TBI-27	neg-TBI-28	neg-TBI-29	neg-TBI-30	neg-TBI-31	neg-TBI-32	neg-TBI-33	neg-TBI-34	neg-TBI-35	neg-TBI-36	neg-TBI-37	neg-TBI-38
Factors	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI	Treatment:TBI
hippuric acid	14.42	11.34	13.85	9.50	11.28	10.33	9.22	8.74	12.25	7.72	11.78	8.54	8.85	12.14	7.55	8.72	8.57	9.00	10.39	8.60	8.93	8.82	8.03	8.06	10.96	12.04	7.90	9.72	7.55	9.15	8.58	8.51	9.37	12.01	9.41	7.64	10.17	8.85	11.21	16.41	11.81	15.24	16.16	11.84	12.64	11.92	12.42	14.47	11.12	14.74	15.12	13.06	11.99	13.21	14.73	13.78	10.59	14.05	16.89	11.30	10.69	12.08	13.23	10.25	8.98	11.02	9.59	10.73	15.87	9.55	8.67	8.14
phenyalanine	0.04	0.02	0.03	0.02	0.03	0.09	0.03	0.03	0.05	0.04	0.07	0.05	0.04	0.04	0.03	0.02	0.02	0.02	0.03	0.04	0.04	0.04	0.03	0.04	0.03	0.06	0.03	0.02	0.02	0.04	0.03	0.02	0.03	0.03	0.02	0.02	0.02	0.01	0.02	0.05	0.02	0.05	0.07	0.03	0.04	0.02	0.07	0.08	0.04	0.06	0.05	0.04	0.03	0.05	0.04	0.04	0.03	0.06	0.05	0.04	0.03	0.04	0.05	0.02	0.02	0.02	0.03	0.02	0.04	0.02	0.01	0.01
urate	0.15	0.05	0.10	0.09	0.18	0.10	0.13	0.04	0.25	0.08	0.10	0.11	0.17	0.11	0.07	0.17	0.07	0.11	0.10	0.16	0.17	0.10	0.13	0.15	0.21	0.20	0.20	0.16	0.19	0.10	0.07	0.17	0.17	0.23	0.09	0.14	0.13	0.04	0.10	0.15	0.05	0.14	0.07	0.05	0.13	0.07	0.10	0.11	0.09	0.12	0.05	0.13	0.06	0.11	0.08	0.11	0.07	0.24	0.06	0.10	0.13	0.08	0.08	0.05	0.08	0.09	0.03	0.13	0.11	0.07	0.09	0.04
hippuric acid2	0.02	0.01	0.02	0.00	0.02	0.01	0.00	0.00	0.01	0.19	0.01	0.00	0.01	0.01	0.00	0.02	0.00	0.00	0.01	0.01	0.01	0.00	0.02	0.01	0.06	0.01	0.01	0.00	0.00	0.02	0.01	0.01	0.00	0.02	0.01	0.00	0.01	0.00	0.07	0.02	0.01	0.01	0.04	0.00	0.01	0.01	0.01	0.04	0.00	0.01	0.01	0.01	0.00	0.02	0.01	0.03	0.00	0.01	0.02	0.01	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.01	0.03	0.04	0.00	0.00
Tryptophan	0.15	0.06	0.13	0.12	0.07	0.15	0.07	0.08	0.12	0.07	0.19	0.07	0.11	0.16	0.10	0.13	0.11	0.10	0.08	0.10	0.11	0.09	0.09	0.08	0.19	0.17	0.10	0.11	0.12	0.08	0.07	0.11	0.16	0.16	0.11	0.05	0.16	0.04	0.09	0.26	0.22	0.18	0.16	0.25	0.16	0.09	0.21	0.15	0.06	0.22	0.24	0.18	0.20	0.16	0.17	0.30	0.17	0.20	0.35	0.10	0.16	0.13	0.23	0.11	0.05	0.11	0.07	0.05	0.14	0.05	0.05	0.05
FFA14:0	0.11	0.20	0.14	0.07	0.23	0.23	0.11	0.15	0.14	0.24	0.16	0.32	0.23	0.06	0.17	0.07	0.15	0.07	0.08	0.40	0.23	0.11	0.11	0.06	0.09	0.10	0.16	0.10	0.10	0.42	0.14	0.18	0.16	0.07	0.11	0.12	0.36	0.22	0.18	1.21	0.18	0.25	0.11	0.13	0.39	0.09	0.43	0.16	0.21	0.23	0.14	0.10	0.16	0.14	0.20	0.09	0.49	0.16	0.18	0.25	0.12	0.12	0.19	0.11	0.21	0.37	0.06	0.15	0.08	0.21	0.08	0.11
FFA16:0	1.38	2.19	2.18	0.93	2.60	3.04	1.34	2.68	2.14	3.75	2.56	5.83	0.78	1.51	2.25	1.24	1.22	1.29	1.11	6.69	0.94	1.37	2.18	1.57	0.88	1.94	3.00	1.60	1.32	7.46	1.49	1.88	1.34	1.92	1.69	2.07	0.83	2.49	3.24	9.87	2.39	3.84	1.64	2.01	5.54	1.48	4.44	3.33	7.00	3.76	2.69	2.53	2.74	2.28	3.29	2.35	5.58	2.44	2.89	1.28	1.47	1.78	1.93	1.71	2.78	2.63	1.38	1.88	0.92	4.16	2.31	1.66
FFA17:1	0.19	0.40	0.62	0.29	0.62	0.86	0.29	1.01	0.52	1.26	0.73	1.87	0.16	0.38	0.72	0.37	0.25	0.34	0.28	1.29	0.31	0.29	0.51	0.39	0.13	0.39	0.82	0.38	0.37	3.02	0.31	0.88	0.36	0.45	0.38	0.49	0.19	0.55	1.12	2.22	0.73	1.36	0.38	0.77	1.91	0.41	1.44	1.02	1.18	1.58	0.85	0.79	0.77	0.96	1.21	0.63	1.60	0.61	0.77	0.44	0.38	0.53	0.52	0.56	0.88	1.16	0.35	0.68	0.32	1.28	0.26	0.44
FFA18:3	0.33	1.86	2.22	0.71	1.78	3.05	0.95	1.51	1.64	4.12	2.53	5.33	0.24	1.34	1.74	1.09	0.99	0.62	0.49	5.05	0.76	0.86	1.34	1.19	0.51	1.85	1.88	0.69	1.42	8.28	0.69	3.17	0.77	0.82	0.83	0.94	0.25	2.01	4.91	10.87	3.45	4.10	1.36	1.27	8.07	1.78	6.02	5.65	71.16	5.59	1.67	3.44	3.35	2.18	2.32	1.90	11.31	1.58	2.34	0.95	1.33	2.71	1.51	0.86	8.35	2.71	0.90	2.46	0.43	4.74	13.23	0.80
FFA18:2	8.52	69.31	67.86	25.87	71.19	109.21	43.01	64.84	63.50	135.87	66.83	211.13	10.06	38.41	72.31	36.70	27.35	30.38	30.63	194.33	21.86	29.72	62.45	56.27	16.90	41.69	104.48	39.78	29.83	331.88	46.66	81.40	30.63	44.69	34.83	37.54	7.69	88.17	163.88	197.21	101.26	143.40	54.23	51.20	251.63	41.53	148.20	152.08	778.02	139.74	89.52	100.93	88.39	93.01	107.12	84.74	274.02	76.76	70.94	43.72	33.69	86.50	63.68	42.96	143.51	99.36	44.56	76.47	18.41	189.51	226.60	32.95
FFA18:1	25.71	224.51	197.22	75.77	284.27	295.11	117.69	235.71	181.00	391.51	213.73	595.03	25.86	141.44	284.04	96.99	70.53	108.13	117.05	565.51	57.21	108.03	194.18	150.39	41.23	150.15	276.42	133.75	101.66	796.44	137.59	198.38	120.06	199.55	146.57	174.68	23.48	288.02	377.45	635.93	253.93	393.51	133.59	196.69	553.11	80.51	409.38	347.78	862.49	436.42	344.26	270.51	290.39	324.52	377.87	265.31	478.39	224.16	299.90	119.05	135.72	191.59	158.87	158.88	317.34	268.19	127.49	207.79	63.41	470.30	222.70	142.59
FFA18:0	0.92	0.88	0.95	0.64	1.26	0.97	0.75	0.95	0.84	1.52	1.41	2.19	0.58	0.82	1.04	0.65	0.54	0.64	0.56	2.14	0.52	0.70	1.12	0.78	0.72	1.08	1.16	0.80	0.82	2.64	0.90	0.92	1.02	1.10	0.81	1.12	0.56	0.97	1.18	3.16	0.87	1.11	0.70	0.75	1.52	0.60	1.17	1.54	4.40	1.41	1.37	1.07	0.89	0.86	1.24	0.96	1.26	1.01	1.17	0.64	0.64	0.81	0.80	0.77	1.04	0.91	0.61	0.92	0.49	0.92	1.19	0.63
FFA20:5	2.63	2.55	3.12	2.38	3.58	2.87	2.45	2.67	2.50	2.84	3.36	4.12	2.70	0.74	2.74	2.55	2.50	2.43	2.28	3.65	2.62	2.37	2.44	2.63	0.77	0.76	2.98	2.71	2.72	4.07	3.11	2.61	3.24	4.41	3.03	4.12	2.04	2.33	4.30	3.78	2.25	3.14	3.22	2.70	4.02	2.55	3.03	3.11	5.23	3.53	3.47	2.88	3.31	2.91	3.69	2.96	3.46	2.94	3.26	2.50	2.85	2.75	3.04	2.84	3.19	3.33	2.45	2.38	2.50	2.89	2.45	2.29
FFA20:4	0.81	1.19	1.61	0.42	1.64	1.77	0.57	1.67	1.37	2.08	1.60	2.38	0.56	0.94	0.73	0.96	0.67	0.51	0.82	3.25	0.54	0.73	1.16	0.99	0.65	0.68	2.38	0.52	1.21	5.87	0.94	0.48	0.59	0.71	0.71	0.82	0.67	1.06	1.23	10.97	1.55	1.80	0.88	1.15	3.73	0.80	2.57	1.50	1.05	2.20	0.87	1.11	1.06	1.04	1.50	1.34	2.66	1.61	1.44	0.66	0.59	0.93	1.26	0.71	1.38	1.78	0.62	0.61	0.72	2.78	0.49	0.47
FFA20:3	0.65	1.23	2.68	0.69	2.05	1.90	1.01	2.25	1.71	3.92	3.11	5.68	0.62	1.58	1.37	0.96	0.66	0.63	0.93	4.87	0.68	0.80	1.89	1.07	0.44	1.18	2.96	1.41	1.18	8.87	0.93	0.82	0.72	0.80	0.73	0.84	0.98	1.22	2.51	19.24	2.19	2.83	0.94	0.91	5.12	1.22	8.64	2.17	2.66	3.33	1.48	2.18	2.04	2.10	1.94	1.74	6.58	2.19	1.80	1.12	0.92	1.73	1.50	0.94	3.19	2.47	0.83	1.24	0.48	2.97	0.54	0.61
FFA20:1	1.42	9.07	8.02	2.95	20.86	8.41	4.47	9.40	5.44	15.28	8.41	26.60	1.61	6.35	18.31	3.11	2.22	3.08	5.57	15.91	1.84	3.66	6.66	5.15	2.09	7.81	8.98	5.02	12.27	30.33	4.32	6.03	4.59	10.03	6.32	6.41	0.86	9.20	12.59	25.79	8.84	14.51	3.80	6.24	15.56	2.63	11.28	12.39	35.40	22.00	26.98	9.75	8.62	13.26	10.59	9.69	9.85	6.63	10.25	4.65	6.61	5.08	4.39	9.00	18.46	16.71	4.50	7.31	2.17	8.08	10.14	4.54
phe-phe	0.01	0.00	0.03	0.01	0.03	0.02	0.01	0.02	0.02	0.01	0.07	0.01	0.02	0.04	0.02	0.02	0.00	0.01	0.01	0.02	0.03	0.01	0.03	0.03	0.02	0.03	0.04	0.02	0.03	0.02	0.03	0.01	0.04	0.01	0.01	0.01	0.01	0.00	0.02	0.20	0.03	0.08	0.08	0.00	0.03	0.07	0.10	0.01	0.06	0.09	0.07	0.13	0.02	0.07	0.05	0.08	0.03	0.06	0.12	0.06	0.21	0.01	0.06	0.03	0.04	0.05	0.12	3.02	0.23	0.00	0.00	0.01
FFA22:6	0.01	0.07	0.19	0.06	0.15	0.09	0.05	0.17	0.17	0.26	0.21	0.51	0.06	0.11	0.09	0.08	0.11	0.06	0.05	0.24	0.09	0.07	0.14	0.08	0.10	0.03	0.15	0.04	0.07	0.55	0.07	0.13	0.06	0.06	0.05	0.07	0.02	0.06	0.12	0.50	0.19	0.10	0.05	0.09	0.65	0.04	0.38	0.18	0.17	0.26	0.14	0.11	0.27	0.09	0.11	0.13	0.11	0.12	0.09	0.06	0.03	0.15	0.08	0.03	0.15	0.33	0.06	0.15	0.04	0.36	0.05	0.07
FFA24:0	2.51	3.34	2.71	2.54	2.38	4.33	1.95	5.60	1.47	2.30	1.60	2.36	1.81	0.77	1.33	4.93	2.56	1.57	2.78	5.07	2.32	2.30	2.89	1.20	1.59	1.80	2.68	1.25	0.46	3.70	2.68	1.43	1.65	2.90	3.44	1.62	5.71	4.62	0.90	3.46	2.36	5.21	3.80	4.85	5.65	1.70	2.12	2.71	4.78	1.59	2.91	2.63	4.13	1.48	2.57	2.88	2.64	2.43	2.78	1.42	2.16	3.17	3.29	0.74	3.57	2.31	3.13	1.24	3.06	2.30	1.47	1.07
DCA(Deoxycholic acid)	0.07	0.01	0.01	0.02	0.02	0.01	0.02	0.01	0.02	0.01	0.02	0.02	0.03	0.01	0.01	0.21	0.02	0.01	0.01	0.02	0.01	0.01	0.01	0.01	0.04	0.01	0.03	0.01	0.01	0.02	0.02	0.03	0.02	0.02	0.01	0.01	0.02	0.03	0.01	0.01	0.01	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
UDCA(Ursodeoxycholic acid)	0.15	0.02	0.02	0.03	0.03	0.02	0.05	0.02	0.02	0.03	0.02	0.02	0.05	0.02	0.03	0.46	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.09	0.02	0.07	0.02	0.02	0.02	0.02	0.06	0.05	0.04	0.02	0.02	0.04	0.07	0.02	0.03	0.03	0.02	0.03	0.02	0.02	0.02	0.02	0.02	0.03	0.02	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.03	0.02	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.02	0.03	0.02	0.02
CA(Cholic acid)	0.05	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.05	0.05	0.04	0.04	0.11	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.05	0.04	0.05	0.04	0.04	0.06	0.04	0.04	0.04	0.12	0.04	0.04	0.05	0.04	0.04	0.05	0.05	0.04	0.04	0.05	0.04	0.04	0.04	0.04	0.05	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.05	0.04	0.04	0.04
GUDCA(Glycoursodeoxycholic acid)	0.23	0.83	0.23	0.22	0.07	2.31	0.32	0.61	0.69	0.61	0.78	0.21	0.46	0.08	0.16	1.22	0.19	0.09	0.24	0.81	0.38	0.54	0.31	0.58	0.26	4.60	0.35	0.15	0.32	0.31	0.31	0.23	3.59	0.64	0.04	0.12	0.27	0.04	0.46	0.70	0.07	1.58	0.22	0.02	0.17	0.08	0.30	0.22	0.18	0.19	0.76	0.09	0.79	0.12	0.05	0.24	0.05	0.10	0.10	0.86	3.20	0.16	0.02	0.14	0.11	0.06	0.05	1.35	1.96	0.07	0.09	0.16
GDCA(Glycodeoxycholic acid)	0.02	0.01	0.00	0.00	0.00	0.03	0.01	0.01	0.01	0.00	0.01	0.00	0.01	0.00	0.00	0.09	0.00	0.01	0.00	0.01	0.00	0.00	0.00	0.01	0.02	0.04	0.06	0.00	0.01	0.01	0.01	0.02	0.07	0.03	0.00	0.00	0.02	0.00	0.01	0.01	0.00	0.02	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.05	0.03	0.01	0.00	0.00
GCA(glycocholic acid)	0.01	0.03	0.01	0.01	0.00	0.05	0.01	0.02	0.02	0.02	0.01	0.00	0.01	0.00	0.00	0.03	0.00	0.00	0.02	0.03	0.01	0.02	0.02	0.01	0.00	0.13	0.01	0.01	0.01	0.02	0.02	0.01	0.27	0.04	0.00	0.01	0.01	0.00	0.01	0.05	0.00	0.06	0.03	0.00	0.01	0.02	0.01	0.02	0.01	0.01	0.04	0.01	0.05	0.02	0.01	0.01	0.00	0.01	0.01	0.04	0.17	0.00	0.02	0.01	0.01	0.00	0.00	0.07	0.24	0.00	0.01	0.01
TDCA(Taurodeoxycholic acid)	0.03	0.06	0.02	0.01	0.01	0.11	0.02	0.06	0.05	0.06	0.05	0.01	0.02	0.01	0.03	0.04	0.02	0.02	0.06	0.04	0.02	0.03	0.04	0.04	0.02	0.20	0.07	0.01	0.01	0.03	0.03	0.03	0.20	0.12	0.01	0.02	0.02	0.01	0.02	0.10	0.01	0.14	0.02	0.01	0.02	0.02	0.02	0.02	0.02	0.03	0.04	0.01	0.04	0.01	0.01	0.01	0.01	0.03	0.01	0.05	0.29	0.01	0.01	0.02	0.01	0.01	0.01	0.06	0.10	0.01	0.01	0.03
TUDCA(Tauroursodeoxycholic acid)	0.03	0.05	0.01	0.01	0.01	0.09	0.02	0.05	0.04	0.05	0.04	0.01	0.02	0.01	0.02	0.04	0.02	0.02	0.05	0.02	0.02	0.03	0.03	0.04	0.02	0.16	0.05	0.01	0.01	0.02	0.03	0.03	0.15	0.10	0.01	0.02	0.02	0.01	0.02	0.09	0.01	0.10	0.02	0.00	0.02	0.01	0.02	0.01	0.02	0.02	0.03	0.01	0.04	0.01	0.00	0.01	0.01	0.02	0.01	0.04	0.24	0.01	0.00	0.02	0.01	0.01	0.01	0.05	0.09	0.01	0.01	0.02
TCDCA(Taurochenodesoxycholic acid)	0.05	0.09	0.02	0.02	0.02	0.16	0.04	0.08	0.07	0.09	0.07	0.03	0.04	0.02	0.04	0.08	0.03	0.04	0.09	0.05	0.03	0.05	0.05	0.06	0.03	0.27	0.11	0.03	0.02	0.04	0.05	0.05	0.27	0.17	0.01	0.03	0.03	0.01	0.04	0.14	0.01	0.18	0.04	0.01	0.03	0.02	0.03	0.03	0.04	0.05	0.06	0.02	0.07	0.02	0.01	0.02	0.02	0.04	0.02	0.07	0.36	0.02	0.02	0.03	0.02	0.02	0.01	0.08	0.15	0.02	0.02	0.04
TCA(Taurocholic acid)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.07	0.01	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.03	0.00	0.00	0.00
GCDCS(Glycochenodeoxycholic acid )	0.61	0.72	0.05	0.09	0.12	0.19	0.38	0.04	0.16	0.58	0.09	0.05	0.02	0.01	0.02	0.12	0.02	0.01	0.05	0.33	0.03	0.06	0.09	0.13	0.02	0.05	0.06	0.03	0.02	0.05	0.15	0.04	0.05	0.34	0.11	0.02	0.21	0.01	0.02	0.05	0.02	0.03	0.06	0.03	0.01	0.02	0.10	0.07	0.00	0.06	0.03	0.03	0.02	0.03	0.02	0.17	0.01	0.07	0.06	0.07	0.05	0.04	0.09	0.03	0.04	0.05	0.03	0.00	0.04	0.03	0.01	0.02
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name
hippuric acid
phenyalanine
urate
hippuric acid2
Tryptophan
FFA14:0
FFA16:0
FFA17:1
FFA18:3
FFA18:2
FFA18:1
FFA18:0
FFA20:5
FFA20:4
FFA20:3
FFA20:1
phe-phe
FFA22:6
FFA24:0
DCA(Deoxycholic acid)
UDCA(Ursodeoxycholic acid)
CA(Cholic acid)
GUDCA(Glycoursodeoxycholic acid)
GDCA(Glycodeoxycholic acid)
GCA(glycocholic acid)
TDCA(Taurodeoxycholic acid)
TUDCA(Tauroursodeoxycholic acid)
TCDCA(Taurochenodesoxycholic acid)
TCA(Taurocholic acid)
GCDCS(Glycochenodeoxycholic acid )
METABOLITES_END
#END